MAOYAN ENT

Forecast & Rating12 analysts currently cover MAOYAN ENT, with about 66.7% giving a positive rating — meaning they expect the stock to rise. The average price target is HK$7.03, about 59.0% upside from the current price of HK$4.43. Price targets range from HK$4.99 to HK$8.57 — a wide spread, showing clear disagreement over just how much MAOYAN ENT can rise. Historically, about 44.7% of past price targets were eventually met, which adds credibility. For you, this means most professionals who study MAOYAN ENT closely still see room for the stock to rise. Data as of Aug 21, 2026; for reference only and not investment advice.